IP Verse

Manufacture Of Degarelix

Patent No. EP4512390 (titled "Manufacture Of Degarelix") was filed by Ferring on May 31, 2013. The application was issued on Jan 28, 2026.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCARE SLUOct 28, 2026BRAND MURRAY FULLER
LEPTHIENOct 28, 2026GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
ZIMMERMANN & PARTNER PATENTANWALTE MBBOct 28, 2026ZIMMERMANN & PARTNER PATENTANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4512390

FERRING
Application Number
EP25151068A
Filing Date
May 31, 2013
Status
Granted And Under Opposition
Dec 26, 2025
Publication Date
Jan 28, 2026
External Links
Slate, Register , Google Patents